Sodium–glucose cotransporter 2 inhibitors reduce myocardial infarct size in preclinical animal models of myocardial ischaemia–reperfusion injury: a meta-analysis

AIMS/HYPOTHESIS: Large cardiovascular outcome trials demonstrated that the cardioprotective effects of sodium–glucose cotransporter 2 (SGLT2) inhibitors might reach beyond glucose-lowering action. In this meta-analysis, we sought to evaluate the potential infarct size-modulating effect of SGLT2 inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayour, Alex Ali, Celeng, Csilla, Oláh, Attila, Ruppert, Mihály, Merkely, Béla, Radovits, Tamás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940278/
https://www.ncbi.nlm.nih.gov/pubmed/33483761
http://dx.doi.org/10.1007/s00125-020-05359-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940278/
https://www.ncbi.nlm.nih.gov/pubmed/33483761
http://dx.doi.org/10.1007/s00125-020-05359-2

Ejemplares similares